Bringing the fundamentals into focus…
Back to Q32 Bio Inc.
How Q32 Bio Inc. stacks up
QTTB · against 318 other Healthcare companies of similar size
Valuation
93/ 100
Near the top of its peers.
Ranked #30 of 319 · scores higher than 90% of peers
Bars: peers in each 10-point band of the valuation score43 peers with a valuation score of 90–100, including QTTB · Click a bar to see the companies
Why valuation scores 93?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -7.6% vs peer median 0.0%
- more operating profit (EBITDA) for the company's total value: stronger than 89% of peers. EBITDA yield: 13.7% vs peer median 4.0%
- higher earnings for the price paid: stronger than 99% of peers. Earnings yield: 35.8% vs peer median 1.5%
Metric by metric
Position: dot = QTTB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | QTTB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 305 reported | 35.8% | -0.4% | 98% | 30% | |
| EBITDA yieldHigher is better · 325 reported | 13.7% | 1.8% | 84% | 50% | |
| Free cash flow yieldHigher is better · 165 reported | -7.6% | -9.4% | 56% | 20% | |
| Book yieldHigher is better · 309 reported | 50.9% | 52.7% | 47% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around QTTB| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 30 | 5.3B TWD (≈$165M) | 93 | 69 | |
| 30 | 55.7B JPY (≈$379M) | 93 | 64 | |
| 30 | 3.6B HKD (≈$463M) | 93 | 61 | |
| 30 | 37.6B JPY (≈$256M) | 93 | 58 | |
| 30 | 261M USD | 93 | 97 | |
| 35 | 1.6B HKD (≈$209M) | 92 | 54 | |
| 35 | 1.1B MYR (≈$245M) | 92 | 70 | |
| 35 | 301M USD | 92 | 67 | |
| 35 | 251M EUR (≈$276M) | 92 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score